Related Experiment Videos
Multiple displacement amplification improves PGD for fragile X syndrome.
P Burlet1, N Frydman, N Gigarel
1Faculté de Médecine, Université Paris-Descartes, Unité INSERM U781 Institut de Recherche Necker-Enfants Malades, Service de génétique médicale, Hôpital Necker-Enfants Malades (Assistance Publique-Hôpitaux de Paris), Paris, France. burlet@necker.fr
Molecular Human Reproduction
|August 10, 2006
Summary
We developed an improved preimplantation genetic diagnosis (PGD) test for fragile X syndrome (FXS) using multiple displacement amplification (MDA). This new method enhances DNA amplification, improving accuracy and success rates for genetic screening in embryos.
Area of Science:
- Genetics
- Reproductive Medicine
- Molecular Biology
Background:
- Fragile X syndrome (FXS) is a significant genetic cause of intellectual disability.
- Current preimplantation genetic diagnosis (PGD) methods for FXS face challenges with DNA amplification and accuracy.
- Multiple displacement amplification (MDA) offers a promising technique for amplifying minute amounts of DNA from single cells.
Purpose of the Study:
- To develop and evaluate an improved PGD test for fragile X syndrome (FXS).
- To integrate multiple displacement amplification (MDA) into the PGD workflow for FXS.
- To enhance the reliability and efficiency of genetic analysis in embryos for FXS.
Main Methods:
- Development of a novel PGD test combining analysis of linked polymorphic markers and the non-expanded CGG repeat in FXS.
- Assessment of single-cell amplification efficiency and allele dropout (ADO) rates using MDA on lymphocytes.
- Application of the MDA-enhanced PGD test in clinical cycles, analyzing 37 embryos from six couples.
Main Results:
- MDA significantly increased embryo amplification rates from 41% to 66%, reducing cases with no results.
- Allele dropout (ADO) rates ranged from 7% to 34% in single-cell lymphocyte analysis.
- The combined direct and indirect genetic analysis improved test reliability, with one clinical pregnancy resulting in a healthy child.
Conclusions:
- The MDA-enhanced PGD test offers a more reliable and efficient diagnostic procedure for fragile X syndrome.
- This improved PGD method could be beneficial for most couples affected by FXS.
- Successful implementation led to a healthy birth, demonstrating the clinical viability of the new test.